086450 — DongKook Pharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- KR₩677bn
- KR₩744bn
- KR₩812bn
- 75
- 60
- 54
- 71
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.76 | ||
| PEG Ratio (f) | 0.52 | ||
| EPS Growth (f) | 20.42% | ||
| Dividend Yield (f) | 1.48% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.13 | ||
| Price to Tang. Book | 1.22 | ||
| Price to Free Cashflow | 15.11 | ||
| Price to Sales | 0.84 | ||
| EV to EBITDA | 6.92 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.16% | ||
| Return on Equity | 10.66% | ||
| Operating Margin | 9.9% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 559,103.46 | 594,193.12 | 661,647.49 | 730,993.6 | 812,166.07 | 890,450 | 981,850 | 10.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -1.15 | -11.29 | +5.61 | -11.14 | +31.28 | +22.04 | +17.57 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DongKook Pharmaceutical Co., Ltd. is a Korea-based company engaged in the development, manufacture and distribution of pharmaceuticals. The Company develops and provides remedies for oral troubles, skin troubles and gynecology diseases, contrast mediums, anesthetics, anticancer medicines and circulatory system agents. It also provides other pharmaceuticals, such as remedies for arthritis and pancreatitis, antiphlogistic, anodynes, antibiotics and vitamins, as well as raw materials for pharmaceuticals. In addition, it is engaged in the rental business. The Company distributes its products within domestic market and to overseas markets, such as Japan, Germany, India, Brazil and Mexico, among others.
Directors
- Heung Ju Oh CEO (58)
- Gi Beom Kwon VCH (46)
- Gyeong Hoe Cha MDR (53)
- Gi Ho Jung MDR (55)
- Hui Seop Kim MDR (54)
- Mok Sun Park MDR (58)
- Byeong Gi Yoo MDR (53)
- Bong Ho Cho OTH (53)
- Se Yil Jeon OTH (54)
- Gyu Jin Jung OTH (46)
- Tae Suk Kim OTH (50)
- Jae Won Park OTH (48)
- Seung Won Pyo OTH (54)
- Byeong Min Yeo DRC (43)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 15th, 1968
- Public Since
- May 29th, 2007
- No. of Shareholders
- 44,017
- No. of Employees
- 757
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 44,392,055
- Address
- Dongkook Pharmaceutical Cheongdam Bldg., SEOUL, 06072
- Web
- https://www.dkpharm.co.kr/
- Phone
- +82 221919800
- Auditors
- KPMG Samjong Accounting Corp
Upcoming Events for 086450
Q2 2025 Dongkook Pharmaceutical Co Ltd Earnings Release
Similar to 086450
AbClon
Korea Exchange - KOSDAQ
ADBiotech Co
Korea Exchange - KOSDAQ
AHN-GOOK PHARMACEUTICAL Co
Korea Exchange - KOSDAQ
Alteogen
Korea Exchange - KOSDAQ
Aminologics Co
Korea Exchange - KOSDAQ
FAQ
What is the DongKook Pharmaceutical Co share price?
As of Today at 20:17 UTC, shares in DongKook Pharmaceutical Co are trading at KR₩15,420. This share price information is delayed by 15 minutes.
How has the DongKook Pharmaceutical Co share price performed this year?
Shares in DongKook Pharmaceutical Co last closed at KR₩15,420 and the price had moved by -3.64% over the past 365 days. In terms of relative price strength the DongKook Pharmaceutical Co share price has underperformed the FTSE Developed Asia Pacific Index by -2.54% over the past year.
What are the analyst and broker recommendations for DongKook Pharmaceutical Co?
The overall consensus recommendation for DongKook Pharmaceutical Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the DongKook Pharmaceutical Co dividend yield?
The DongKook Pharmaceutical Co dividend yield is 1.3% based on the trailing twelve month period.
Does DongKook Pharmaceutical Co pay a dividend?
Last year, DongKook Pharmaceutical Co paid a total dividend of KR₩200, and it currently has a trailing dividend yield of 1.3%. We do not have any data on when DongKook Pharmaceutical Co is to next pay dividends.
When does DongKook Pharmaceutical Co next pay dividends?
We do not have data on when DongKook Pharmaceutical Co is to next pay dividends. The historic dividend yield on DongKook Pharmaceutical Co shares is currently 1.3%.
How do I buy DongKook Pharmaceutical Co shares?
To buy shares in DongKook Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of DongKook Pharmaceutical Co?
As of the previous close price of KR₩15,420, shares in DongKook Pharmaceutical Co had a market capitalisation of KR₩677bn.
Where are DongKook Pharmaceutical Co shares listed?
Here are the trading details for DongKook Pharmaceutical Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 086450
What kind of share is DongKook Pharmaceutical Co?
Based on an overall assessment of its quality, value and momentum DongKook Pharmaceutical Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a DongKook Pharmaceutical Co share price forecast for 2025?
The analyst consensus target price for shares in DongKook Pharmaceutical Co is KR₩25,784. That is 67.21% above the last closing price of KR₩15,420.
Analysts covering DongKook Pharmaceutical Co currently have a consensus Earnings Per Share (EPS) forecast of KR₩1,668 for the next financial year.
Find out moreWhat is the trend in the DongKook Pharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DongKook Pharmaceutical Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -5.43%.
As of the last closing price of KR₩15,420, shares in DongKook Pharmaceutical Co were trading -7.3% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the DongKook Pharmaceutical Co PE Ratio?
The DongKook Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 8.76. The shares last closed at KR₩15,420.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of DongKook Pharmaceutical Co?
DongKook Pharmaceutical Co's management team is headed by:
- Heung Ju Oh - CEO
- Gi Beom Kwon - VCH
- Gyeong Hoe Cha - MDR
- Gi Ho Jung - MDR
- Hui Seop Kim - MDR
- Mok Sun Park - MDR
- Byeong Gi Yoo - MDR
- Bong Ho Cho - OTH
- Se Yil Jeon - OTH
- Gyu Jin Jung - OTH
- Tae Suk Kim - OTH
- Jae Won Park - OTH
- Seung Won Pyo - OTH
- Byeong Min Yeo - DRC